MedPath

SANOCULIS LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:1
Completed:7

Trial Phases

1 Phases

Not Applicable:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (100.0%)

This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.

Not Applicable
Active, not recruiting
Conditions
Glaucoma
Ocular Hypertension
Open-Angle Glaucoma
First Posted Date
2025-07-23
Last Posted Date
2025-07-23
Lead Sponsor
Sanoculis Ltd
Target Recruit Count
47
Registration Number
NCT07081347
Locations
🇦🇲

Ophthalmological Center After S.V Malayan, Yerevan, Armenia

The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)

Not Applicable
Completed
Conditions
Glaucoma
First Posted Date
2025-07-04
Last Posted Date
2025-07-04
Lead Sponsor
Sanoculis Ltd
Target Recruit Count
88
Registration Number
NCT07051174
Locations
🇦🇲

Malayan, Yerevan, Armenia

MIMS® Retrospective Chart Review

Not yet recruiting
Conditions
Open Angle Glaucoma
First Posted Date
2024-09-26
Last Posted Date
2025-01-10
Lead Sponsor
Sanoculis Ltd
Target Recruit Count
40
Registration Number
NCT06614218
Locations
🇦🇲

S. Malayan Eye Center, Yerevan, Armenia

Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

Completed
Conditions
Open Angle Glaucoma
First Posted Date
2024-09-25
Last Posted Date
2025-01-10
Lead Sponsor
Sanoculis Ltd
Target Recruit Count
36
Registration Number
NCT06612346
Locations
🇦🇲

S. Malayan Eye Center, Yerevan, Armenia

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study

Recruiting
Conditions
Open Angle Glaucoma
First Posted Date
2024-08-29
Last Posted Date
2024-08-29
Lead Sponsor
Sanoculis Ltd
Target Recruit Count
53
Registration Number
NCT06577857
Locations
🇦🇲

S. Malayan Eye Center, Yerevan, Armenia

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.